Compounds > vatalanib
Page last updated: 2024-09-04

vatalanib and n-(6-chloro-7-methoxy-9h-beta-carbolin-8-yl)-2-methylnicotinamide

vatalanib has been researched along with n-(6-chloro-7-methoxy-9h-beta-carbolin-8-yl)-2-methylnicotinamide in 1 studies

Compound Research Comparison

Studies
(vatalanib)		Trials
(vatalanib)		Recent Studies (post-2010)
(vatalanib)		Studies
(n-(6-chloro-7-methoxy-9h-beta-carbolin-8-yl)-2-methylnicotinamide)		Trials
(n-(6-chloro-7-methoxy-9h-beta-carbolin-8-yl)-2-methylnicotinamide)		Recent Studies (post-2010) (n-(6-chloro-7-methoxy-9h-beta-carbolin-8-yl)-2-methylnicotinamide)
276429816013

Protein Interaction Comparison

ProteinTaxonomyvatalanib (IC50)n-(6-chloro-7-methoxy-9h-beta-carbolin-8-yl)-2-methylnicotinamide (IC50)
Inhibitor of nuclear factor kappa-B kinase subunit betaHomo sapiens (human)0.255

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ciceri, P; Davis, MI; Herrgard, S; Hocker, M; Hunt, JP; Pallares, G; Treiber, DK; Wodicka, LM; Zarrinkar, PP1

Other Studies

1 other study(ies) available for vatalanib and n-(6-chloro-7-methoxy-9h-beta-carbolin-8-yl)-2-methylnicotinamide

ArticleYear
Comprehensive analysis of kinase inhibitor selectivity.
    Nature biotechnology, 2011, Oct-30, Volume: 29, Issue:11

    Topics: Catalysis; Drug Design; Enzyme Stability; High-Throughput Screening Assays; Humans; Protein Binding; Protein Kinase Inhibitors; Protein Kinases; Proteomics; Signal Transduction; Substrate Specificity

2011